Company Profile

Ash Access Technology, Inc. is an integrated specialty pharmaceutical / medical device company engaged in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company has an advanced portfolio of innovative products targeting catheter-related bloodstream infections (CRBSI) and poor patency (blood flow) – the significant challenges associated with the use of both acute and chronic catheters for vascular access. The company was founded in 2003 involving principals of earlier SBIR involved firms. The team’s comprehensive understanding of vascular access devices, their complications and clinical consequences, combined with the proven ability for product development and commercialization, creates an organization that is well positioned to make a unique and significant impact in the lives of patients suffering from the consequences of vascular access complications. * Discovering, formulating, clinical testing and commercializing a novel antimicrobial / antithrombotic therapy (Zuragen™) for the prevention and treatment of CRBSI as well as the eradication of biofilm. * Building a dynamic hemodialysis and peritoneal dialysis catheter portfolio to include an innovative open / closed lumen tip design and other technological advances which are significant advances over the original Ash Split Cath® (Medcomp®, 1996) design. * Pursuing the integration of Zuragen™ technology with our catheter designs to form a novel eluting device that creates a barrier for infection which would potentially last months instead of days. Ash Access Technology, Inc. operates as an integrated specialty pharmaceutical/medical device company. It engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company provides Zuragen, an antimicrobial/antithrombotic therapy; and Ash SureFlow, an long-term tunneled central venous catheter for hemodialysis. The company was founded in 1983 as Ash Medical Systems, Inc. and changed its name to Ash Access Technology, Inc